China’s FDA aims to speed drug OKs with shift to U.S.-style clinical trial application process
China’s FDA is proposing another round of policy changes designed to hasten clinical trial approval and lift restrictions placed on trial sites, with the ultimate goal of allowing drugs to get into the clinic faster.